Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Non-Current Deferred Tax Liability: 2018-2024

Historic Non-Current Deferred Tax Liability for Ptc Therapeutics (PTCT) over the last 6 years, with Sep 2024 value amounting to $55.9 million.

  • Ptc Therapeutics' Non-Current Deferred Tax Liability rose 7.67% to $55.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $55.9 million, marking a year-over-year increase of 7.67%. This contributed to the annual value of $55.9 million for FY2023, which is 45.64% down from last year.
  • According to the latest figures from Q3 2024, Ptc Therapeutics' Non-Current Deferred Tax Liability is $55.9 million, which was down 0.00% from $55.9 million recorded in Q2 2024.
  • In the past 5 years, Ptc Therapeutics' Non-Current Deferred Tax Liability ranged from a high of $137.1 million in Q4 2021 and a low of $51.9 million during Q3 2023.
  • Its 3-year average for Non-Current Deferred Tax Liability is $85.9 million, with a median of $55.9 million in 2024.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first plummeted by 62.13% in 2023, then rose by 7.67% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Non-Current Deferred Tax Liability (Quarterly) stood at $136.7 million in 2020, then grew by 0.27% to $137.1 million in 2021, then dropped by 25.00% to $102.8 million in 2022, then tumbled by 45.64% to $55.9 million in 2023, then increased by 7.67% to $55.9 million in 2024.
  • Its Non-Current Deferred Tax Liability stands at $55.9 million for Q3 2024, versus $55.9 million for Q2 2024 and $55.9 million for Q1 2024.